Refractory celiac disease type 2: how to diagnose and treat?

Detalhes bibliográficos
Autor(a) principal: Soldera,Jonathan
Data de Publicação: 2021
Outros Autores: Salgado,Karina, Pêgas,Karla Lais
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300168
Resumo: SUMMARY Refractory celiac disease is an uncommon condition which might be associated to poor prognosis. It is often treated with immunosuppressive medications, with poor results. It is divided in type 1 and type 2, the latter carrying a high risk for lymphoma and mortality. A case of a 41 year old female patient with refractory celiac disease type 2 is reported. She was treated with oral budesonide for six months, achieving histological remission.
id AMB-1_5dd544939c471c1e33b820dc99ab7f03
oai_identifier_str oai:scielo:S0104-42302021000300168
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Refractory celiac disease type 2: how to diagnose and treat?Celiac diseaseBudesonideDiet, gluten-freeSUMMARY Refractory celiac disease is an uncommon condition which might be associated to poor prognosis. It is often treated with immunosuppressive medications, with poor results. It is divided in type 1 and type 2, the latter carrying a high risk for lymphoma and mortality. A case of a 41 year old female patient with refractory celiac disease type 2 is reported. She was treated with oral budesonide for six months, achieving histological remission.Associação Médica Brasileira2021-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300168Revista da Associação Médica Brasileira v.67 n.2 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.67.02.20200618info:eu-repo/semantics/openAccessSoldera,JonathanSalgado,KarinaPêgas,Karla Laiseng2021-08-12T00:00:00Zoai:scielo:S0104-42302021000300168Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-08-12T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Refractory celiac disease type 2: how to diagnose and treat?
title Refractory celiac disease type 2: how to diagnose and treat?
spellingShingle Refractory celiac disease type 2: how to diagnose and treat?
Soldera,Jonathan
Celiac disease
Budesonide
Diet, gluten-free
title_short Refractory celiac disease type 2: how to diagnose and treat?
title_full Refractory celiac disease type 2: how to diagnose and treat?
title_fullStr Refractory celiac disease type 2: how to diagnose and treat?
title_full_unstemmed Refractory celiac disease type 2: how to diagnose and treat?
title_sort Refractory celiac disease type 2: how to diagnose and treat?
author Soldera,Jonathan
author_facet Soldera,Jonathan
Salgado,Karina
Pêgas,Karla Lais
author_role author
author2 Salgado,Karina
Pêgas,Karla Lais
author2_role author
author
dc.contributor.author.fl_str_mv Soldera,Jonathan
Salgado,Karina
Pêgas,Karla Lais
dc.subject.por.fl_str_mv Celiac disease
Budesonide
Diet, gluten-free
topic Celiac disease
Budesonide
Diet, gluten-free
description SUMMARY Refractory celiac disease is an uncommon condition which might be associated to poor prognosis. It is often treated with immunosuppressive medications, with poor results. It is divided in type 1 and type 2, the latter carrying a high risk for lymphoma and mortality. A case of a 41 year old female patient with refractory celiac disease type 2 is reported. She was treated with oral budesonide for six months, achieving histological remission.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300168
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300168
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.67.02.20200618
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.67 n.2 2021
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212836014292992

Registros relacionados